Rupa, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Rupa, Inc. - overview

Established

2018

Location

San Francisco, CA, US

Primary Industry

Healthcare

About

Based in California, US, and founded in 2020 by CEO Tara Viswanathan, Rupa, Inc. , d. b. a.


Rupa Health is a telehealth company that provides lab testing from different laboratory companies to power the next evolution of medicine. In March 2022, Rupa, Inc. raised USD 20 million in a Series A funding led by Bessemer Venture Partners, with participation from Operator Collective, First Round Capital, Floodgate, SV Angel, and Edit The Chainsmokers, along with other unspecified and individual investors. In October 2024, Natural Partners Inc.


, a portfolio company of HGGC, Kayne Anderson Capital Advisors, and Snapdragon Capital Partners, acquired Rupa, Inc. from Bessemer Venture Partners, First Round Capital, Floodgate, Operator Collective, SV Angel, and The Chainsmokers. Financial terms were not disclosed. Rupa, Inc.


provides a digital platform that connects practitioners with specialty and traditional labs and mobile phlebotomists to make the entire process seamless for patients and practitioners. The company’s platform powers diagnostics for clinics, solo practices, and hospital groups, such as Bastyr University, UC Irvine Susan Samueli Institute, George Washington University, and more. As of March 2022, Rupa, Inc. has partnered with about 25 laboratories to give access to more than 3,000 traditional and specialty tests.


Rupa, Inc. generates revenues from charging test prices along with a 7% ordering fee. Rupa, Inc. plans to use its proceeds from March 2022 funding to meet an increasing practitioner and patient demands, as well as expand its business reach.


The company also plans to provide the latest diagnostic tools to its network of practitioners by building educational resources and expanding the lab catalog.


Current Investors

First Round Capital, SV Angel, Floodgate

Primary Industry

Healthcare

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Healthcare IT

Website

www.rupahealth.com/

Verticals

HealthTech

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.